Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Colorectal Neoplasms
×
lenvatinib
×
Clear all
Filters
3
NCT04776148
2026-02-05
MK-7902-017
Merck Sharp & Dohme LLC
Phase 3
Completed
563 enrolled
32 charts